Feasibility of Powered Intracapsular Tonsillectomy in Pediatric Patients with Tonsil Problem, Including Recurrent Tonsillitis: A Single Surgeon's Experience

被引:0
|
作者
Kim, Heejin [1 ]
Li, Sung Won [1 ]
Park, Sung Min [1 ]
Kim, Sung Kyun [1 ]
Hong, Seok Jin [1 ]
Hong, Seok Min [1 ]
Kim, Young Bok [1 ]
Park, Il Seok [1 ]
机构
[1] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Hwaseong, South Korea
基金
新加坡国家研究基金会;
关键词
Tonsillectomy; Microdebrider; Intracapsular tonsillectomy; Postoperative hemorrhage; Tonsillitis; OBSTRUCTIVE SLEEP-APNEA; MICRODEBRIDER; CHILDREN; COMPLICATIONS; EFFICACY; ELECTROCAUTERY;
D O I
10.1159/000509479
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: Powered intracapsular tonsillectomy (PIT) is a technique that protects the tonsillar capsule by using a microdebrider, resulting in faster wound-healing and reduced suffering. Many studies have found PIT to be effective, particularly in pediatric patients with obstructive sleep apnea (OSA). However, previous studies have not included patients with a history of recurrent tonsillitis. Objective: The aim of this study was to determine the efficacy of PIT in pediatric patients even with a history of recurrent tonsillitis, and therefore, we want to expand the indication for PIT and reveal its safety. Methods: A total of 886 pediatric patients underwent PIT between February 2013 and March 2016. All patients rated their postoperative pain using a visual analog scale (VAS) and completed the Korean obstructive sleep apnea (KOSA)-18 questionnaire for assessment of their quality of life (QOL). There were 539 males and 347 females. Their mean age was 6.2 years (range 2-14 years). The majority (77.7%) underwent the operation for OSA, and the rest (22.3%) had a history of recurrent tonsillitis. To compare the efficacy of PIT with traditional tonsillectomy, we selected 191 patients who underwent extracapsular tonsillectomy (ECT), a conventional technique, during the same time period. The median follow-up period was 16.7 months. During the follow-up period, instances of delayed bleeding and recurrent pharyngitis were monitored. Results: In comparison to the patients who underwent ECT, the PIT group showed significantly fewer cases of postoperative bleeding (p = 0.027). Thirteen patients in the PIT group (1.5%) visited the hospital during the follow-up period for pharyngitis, while 8 in the ECT group (4.2%) visited for pharyngitis. The mean postoperative pain score, as assessed by a VAS, was 4.6 +/- 3.2, and pain improved within an average of 2.9 days after surgery in the PIT group. The mean KOSA-18 score for the QOL of the patients was 65.9 preoperatively and 35.6 postoperatively in the PIT group. Conclusions: Pediatric tonsillectomy using PIT is valid for reducing postoperative pain and improving the QOL of OSA patients. PIT is also effective and safe for patients with a history of recurrent tonsillitis.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 4 条
  • [1] Longitudinal outcomes with intracapsular tonsillectomy, a single surgeon's experience
    Bouzaher, Malek H.
    Hewes, Daniel
    Belfiglio, Mario
    Anne, Samantha
    Abelson, Tom
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (02)
  • [2] Ablative Fractional Photothermolysis for the Treatment of Hypertrophic Burn Scars in Adult and Pediatric Patients: A Single Surgeon's Experience
    Khandelwal, Anjay
    Yelvington, Miranda
    Tang, Xinyu
    Brown, Susan
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2014, 35 (05): : 455 - 463
  • [3] An 8-year Review of a Single Breast Surgeon's Experience with Same-day Discharge for Mastectomy Patients, Including Patients with Bilateral Procedures with or without Immediate Reconstruction
    Bumberry, John
    York, Catherine
    Meystrik, Rosellen
    Shah, Bharat
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S626 - S627
  • [4] ADVL1514, a phase 1 study of ABI-009 (nab-sirolimus) in pediatric patients with recurrent or refractory solid tumors, including CNS tumors as a single agent and in combination with temozolomide and irinotecan: A Children's Oncology Group pediatric early-phase clinical trial network study.
    Cramer, Stuart
    Gilger, Elizabeth Ann
    Burlingame, Susan
    Militano, Olga
    Liu, Xiaowei
    Minard, Charles G.
    Reddy, Alyssa Terry
    Voss, Stephan D.
    Berg, Stacey L.
    Reid, Joel M.
    Fox, Elizabeth
    Weigel, Brenda
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)